You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.